Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Pediatr Res. 2020 Aug;88(Suppl 1):48–55. doi: 10.1038/s41390-020-1080-6

Table 4:

NEC in cohort studies including at least 1000 preterm infants

Cohort Probiotic (NEC/total) No Probiotic (NEC/total) RR (95% CI)
Guthmann (65) 8/591 33/633 0.26 (0.12, 0.56)
Hartel (66) 116/3789 76/1562 0.63 (0.47, 0.84)
Bonsante (67) 4/347 41/783 0.22 (0.080, 0.61)
Hoyosa (68) 34/1237 85/1282 0.41 (0.28, 0.61)
Luoto (69) 19/418 61/1900 1.4 (0.86, 2.3)
Denkel (70) 100/5818 174/5072 0.50 (0.39, 0.64)
Patole (71) 12/920 25/835 0.44 (0.22, 0.86)
Samuels (72) 34/673 101/1288 0.64 (0.44, 0.94)
Sharpe (73) 7/457 37/1334 0.55 (0.25, 1.2)
Singhb (74) 50/652 190/2436 0.98 (0.73, 1.3)
Meyer (75) 35/1973 70/2556 0.62 (0.41, 0.94)
a

included infants of all gestational ages

b

probiotics decreased NEC with multiple logistic regression models adjusted for gestational age, SNAPII scores > 20, outborn status, and any breast milk intake (aOR 0.64, 95% CI 0.41, 0.996).